344 related articles for article (PubMed ID: 19477415)
41. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR
Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078
[TBL] [Abstract][Full Text] [Related]
42. Mycolic acids: structures, biosynthesis, and beyond.
Marrakchi H; Lanéelle MA; Daffé M
Chem Biol; 2014 Jan; 21(1):67-85. PubMed ID: 24374164
[TBL] [Abstract][Full Text] [Related]
43. Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
Alsayed SSR; Beh CC; Foster NR; Payne AD; Yu Y; Gunosewoyo H
Curr Mol Pharmacol; 2019; 12(1):27-49. PubMed ID: 30360731
[TBL] [Abstract][Full Text] [Related]
44. Purification, characterization, and mass spectrometric sequencing of a medium chain acyl-CoA synthetase from mouse liver mitochondria and comparisons with the homologues of rat and bovine.
Kasuya F; Tatsuki T; Ohta M; Kawai Y; Igarashi K
Protein Expr Purif; 2006 Jun; 47(2):405-14. PubMed ID: 16378734
[TBL] [Abstract][Full Text] [Related]
45. MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II.
Marrakchi H; Ducasse S; Labesse G; Montrozier H; Margeat E; Emorine L; Charpentier X; Daffé M; Quémard AK
Microbiology (Reading); 2002 Apr; 148(Pt 4):951-960. PubMed ID: 11932442
[TBL] [Abstract][Full Text] [Related]
46. Electrospray ionization-tandem mass spectrometry analysis of the mycolic acid profiles for the identification of common clinical isolates of mycobacterial species.
Song SH; Park KU; Lee JH; Kim EC; Kim JQ; Song J
J Microbiol Methods; 2009 May; 77(2):165-77. PubMed ID: 19318047
[TBL] [Abstract][Full Text] [Related]
47. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
Stanley SA; Kawate T; Iwase N; Shimizu M; Clatworthy AE; Kazyanskaya E; Sacchettini JC; Ioerger TR; Siddiqi NA; Minami S; Aquadro JA; Grant SS; Rubin EJ; Hung DT
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11565-70. PubMed ID: 23798446
[TBL] [Abstract][Full Text] [Related]
48. Cholesteroid nature of free mycolic acids from M. tuberculosis.
Benadie Y; Deysel M; Siko DG; Roberts VV; Van Wyngaardt S; Thanyani ST; Sekanka G; Ten Bokum AM; Collett LA; Grooten J; Baird MS; Verschoor JA
Chem Phys Lipids; 2008 Apr; 152(2):95-103. PubMed ID: 18312856
[TBL] [Abstract][Full Text] [Related]
49. Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial lipids.
Gokhale RS; Saxena P; Chopra T; Mohanty D
Nat Prod Rep; 2007 Apr; 24(2):267-77. PubMed ID: 17389997
[TBL] [Abstract][Full Text] [Related]
50. Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids.
Morbidoni HR; Vilchèze C; Kremer L; Bittman R; Sacchettini JC; Jacobs WR
Chem Biol; 2006 Mar; 13(3):297-307. PubMed ID: 16638535
[TBL] [Abstract][Full Text] [Related]
51. A new subfamily of short bacterial adenylate kinases with the Mycobacterium tuberculosis enzyme as a model: A predictive and experimental study.
Munier-Lehmann H; Burlacu-Miron S; Craescu CT; Mantsch HH; Schultz CP
Proteins; 1999 Aug; 36(2):238-48. PubMed ID: 10398370
[TBL] [Abstract][Full Text] [Related]
52. Purification and characterization of the Mycobacterium tuberculosis FabD2, a novel malonyl-CoA:AcpM transacylase of fatty acid synthase.
Huang YS; Ge J; Zhang HM; Lei JQ; Zhang XL; Wang HH
Protein Expr Purif; 2006 Feb; 45(2):393-9. PubMed ID: 16112872
[TBL] [Abstract][Full Text] [Related]
53. Negative regulation by Ser/Thr phosphorylation of HadAB and HadBC dehydratases from Mycobacterium tuberculosis type II fatty acid synthase system.
Slama N; Leiba J; Eynard N; Daffé M; Kremer L; Quémard A; Molle V
Biochem Biophys Res Commun; 2011 Sep; 412(3):401-6. PubMed ID: 21819969
[TBL] [Abstract][Full Text] [Related]
54. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
[TBL] [Abstract][Full Text] [Related]
55. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
[TBL] [Abstract][Full Text] [Related]
56. Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue.
Sakallioglu IT; Maroli AS; De Lima Leite A; Marshall DD; Evans BW; Zinniel DK; Dussault PH; Barletta RG; Powers R
J Am Chem Soc; 2022 Nov; 144(46):21157-21173. PubMed ID: 36367461
[TBL] [Abstract][Full Text] [Related]
57. Isolation and analysis of Mycobacterium tuberculosis mycolic acids.
Vilchèze C; Jacobs WR
Curr Protoc Microbiol; 2007 Jun; Chapter 10():Unit 10A.3. PubMed ID: 18770604
[TBL] [Abstract][Full Text] [Related]
58. Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis.
Gande R; Gibson KJ; Brown AK; Krumbach K; Dover LG; Sahm H; Shioyama S; Oikawa T; Besra GS; Eggeling L
J Biol Chem; 2004 Oct; 279(43):44847-57. PubMed ID: 15308633
[TBL] [Abstract][Full Text] [Related]
59. Crystal structures of FadD32 and pks13-ACP domain from Corynebacterium diphtheriae.
Chen R; Yuan J; Shi X; Tang W; Liu X
Biochem Biophys Res Commun; 2022 Jan; 590():152-157. PubMed ID: 34974304
[TBL] [Abstract][Full Text] [Related]
60. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.
Huang CC; Smith CV; Glickman MS; Jacobs WR; Sacchettini JC
J Biol Chem; 2002 Mar; 277(13):11559-69. PubMed ID: 11756461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
